VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $34,000 | -12.8% | 2,085 | -28.9% | 0.00% | – |
| Q3 2019 | $39,000 | -25.0% | 2,931 | -21.0% | 0.00% | – |
| Q2 2019 | $52,000 | -23.5% | 3,712 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $68,000 | -11.7% | 3,712 | +27.3% | 0.00% | 0.0% |
| Q4 2018 | $77,000 | +92.5% | 2,916 | +66.2% | 0.00% | – |
| Q3 2018 | $40,000 | +21.2% | 1,755 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | +10.0% | 1,755 | 0.0% | 0.00% | – |
| Q1 2018 | $30,000 | +11.1% | 1,755 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | -12.9% | 1,755 | 0.0% | 0.00% | – |
| Q3 2017 | $31,000 | +6.9% | 1,755 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $29,000 | +16.0% | 1,755 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $25,000 | – | 1,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |